Nurse Practitioner · Gardena, CA
NPI
1053705533
Since 2015
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
15803 S Maple Ave
Gardena, CA, 90248
Phone (310) 469-4273
Groups this clinician bills Medicare through
Medicare paid, 2024
$915
13 services
Medicare patients, 2024
11
Average age 59
Drug cost, 2024
$792K
3,242 prescriptions
Company payments, 2025
$70.22
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Anna Smith prescribed most often to Medicare patients was Metformin Hcl, with 279 prescriptions and refills. In total Anna Smith wrote 3,242 Medicare prescriptions that cost $792K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Metformin Hcl Generic | 279 | 902 | 98 | $3,556 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 278 | 728 | 114 | $8,288 |
| Glipizide Generic | 274 | 879 | 115 | $3,815 |
| Humulin N Insulin Nph Human Isophane | 265 | 758 | 111 | $52K |
| Humulin R Insulin Regular, Human | 251 | 628 | 95 | $29K |
| Ozempic Semaglutide | 224 | 235 | 45 | $169K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 204 | 525 | 71 | $48K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 159 | 431 | 68 | $4,020 |
| Insulin Glargine-Yfgn Generic | 129 | 342 | 63 | $15K |
| Humalog Insulin Lispro | 128 | 321 | 51 | $24K |
| Veo Insulin Syringe Syringe And Needle,insulin,1ml | 122 | 355 | 59 | $3,421 |
| Humalog Kwikpen U-100 Insulin Lispro | 119 | 302 | 50 | $39K |
| Metformin Hcl Er Metformin Hcl | 103 | 325 | 44 | $986 |
| Veo Insulin Syringe Syrge-Ndl,ins 0.3 Ml Half Mark | 85 | 187 | 42 | $1,869 |
| Jardiance Empagliflozin | 83 | 270 | 41 | $53K |
Brand drugs: 1,722 claims; generic drugs: 818 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Smith $70.22 ($70.22 in general payments such as food, travel and fees) from 2 companies. The largest payer was Neurocrine BioSciences, Inc. with $46.22.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.